Lattanzio R - Search Results

1

The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma.

Cicirò Y, Ragusa D, Nevado PT, Lattanzio R, Sala G, DesRochers T, Millard M, Andersson MK, Stenman G, Sala A. Cicirò Y, et al. Among authors: lattanzio r. FEBS Lett. 2024 Jan;598(2):252-265. doi: 10.1002/1873-3468.14786. Epub 2023 Dec 27. FEBS Lett. 2024. PMID: 38112379

2

Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6) in breast cancer.

Corda G, Sala G, Lattanzio R, Iezzi M, Sallese M, Fragassi G, Lamolinara A, Mirza H, Barcaroli D, Ermler S, Silva E, Yasaei H, Newbold RF, Vagnarelli P, Mottolese M, Natali PG, Perracchio L, Quist J, Grigoriadis A, Marra P, Tutt AN, Piantelli M, Iacobelli S, De Laurenzi V, Sala A. Corda G, et al. Among authors: lattanzio r. J Pathol. 2017 Feb;241(3):350-361. doi: 10.1002/path.4841. Epub 2016 Dec 29. J Pathol. 2017. PMID: 27859262 Free PMC article.

3

The role of phospholipase Cγ1 in breast cancer and its clinical significance.

Emmanouilidi A, Lattanzio R, Sala G, Piantelli M, Falasca M. Emmanouilidi A, et al. Among authors: lattanzio r. Future Oncol. 2017 Sep;13(22):1991-1997. doi: 10.2217/fon-2017-0125. Epub 2017 Aug 22. Future Oncol. 2017. PMID: 28829192

4

ABCC3 is a novel target for the treatment of pancreatic cancer.

Adamska A, Ferro R, Lattanzio R, Capone E, Domenichini A, Damiani V, Chiorino G, Akkaya BG, Linton KJ, De Laurenzi V, Sala G, Falasca M. Adamska A, et al. Among authors: lattanzio r. Adv Biol Regul. 2019 Aug;73:100634. doi: 10.1016/j.jbior.2019.04.004. Epub 2019 Apr 24. Adv Biol Regul. 2019. PMID: 31053501

5

Preclinical validation of 3-phosphoinositide-dependent protein kinase 1 inhibition in pancreatic cancer.

Emmanouilidi A, Fyffe CA, Ferro R, Edling CE, Capone E, Sestito S, Rapposelli S, Lattanzio R, Iacobelli S, Sala G, Maffucci T, Falasca M. Emmanouilidi A, et al. Among authors: lattanzio r. J Exp Clin Cancer Res. 2019 May 14;38(1):191. doi: 10.1186/s13046-019-1191-2. J Exp Clin Cancer Res. 2019. PMID: 31088502 Free PMC article.

6

PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes.

Lattanzio R, Iezzi M, Sala G, Tinari N, Falasca M, Alberti S, Buglioni S, Mottolese M, Perracchio L, Natali PG, Piantelli M. Lattanzio R, et al. BMC Cancer. 2019 Jul 30;19(1):747. doi: 10.1186/s12885-019-5949-x. BMC Cancer. 2019. PMID: 31362705 Free PMC article.

7

Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma.

Capone E, Lamolinara A, Pastorino F, Gentile R, Ponziani S, Di Vittorio G, D'Agostino D, Bibbò S, Rossi C, Piccolo E, Iacobelli V, Lattanzio R, Panella V, Sallese M, De Laurenzi V, Giansanti F, Sala A, Iezzi M, Ponzoni M, Ippoliti R, Iacobelli S, Sala G. Capone E, et al. Among authors: lattanzio r. Cancers (Basel). 2020 Oct 15;12(10):2989. doi: 10.3390/cancers12102989. Cancers (Basel). 2020. PMID: 33076448 Free PMC article.

8

USP19 modulates cancer cell migration and invasion and acts as a novel prognostic marker in patients with early breast cancer.

Rossi FA, Enriqué Steinberg JH, Calvo Roitberg EH, Joshi MU, Pandey A, Abba MC, Dufrusine B, Buglioni S, De Laurenzi V, Sala G, Lattanzio R, Espinosa JM, Rossi M. Rossi FA, et al. Among authors: lattanzio r. Oncogenesis. 2021 Mar 13;10(3):28. doi: 10.1038/s41389-021-00318-x. Oncogenesis. 2021. PMID: 33714979 Free PMC article.

9

EV20/NMS-P945, a Novel Thienoindole Based Antibody-Drug Conjugate Targeting HER-3 for Solid Tumors.

Capone E, Lattanzio R, Gasparri F, Orsini P, Rossi C, Iacobelli V, De Laurenzi V, Natali PG, Valsasina B, Iacobelli S, Sala G. Capone E, et al. Among authors: lattanzio r. Pharmaceutics. 2021 Apr 2;13(4):483. doi: 10.3390/pharmaceutics13040483. Pharmaceutics. 2021. PMID: 33918158 Free PMC article.

10

Extracellular LGALS3BP: a potential disease marker and actionable target for antibody-drug conjugate therapy in glioblastoma.

Dufrusine B, Capone E, Ponziani S, Lattanzio R, Lanuti P, Giansanti F, De Laurenzi V, Iacobelli S, Ippoliti R, Mangiola A, Trevisi G, Sala G. Dufrusine B, et al. Among authors: lattanzio r. Mol Oncol. 2023 Aug;17(8):1460-1473. doi: 10.1002/1878-0261.13453. Epub 2023 Jun 7. Mol Oncol. 2023. PMID: 37195369 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

221 results

Search Page